memo – magazine of european medical oncology
“memo – magazine of european medical oncology“
was founded in 2008 by Springer Verlag Wien in cooperation with Prof. Wolfgang Hilbe, (WSP Vienna; formerly at the University Clinic Innsbruck) who since then serves as Editor in Chief.
The focus of the journal is to offer a professional review on current research and development in the field of haematology and oncology relevant for daily practice. Therefore, “memo” includes editorials and comments, peer-reviewed original reports, short reviews, case reports and controversies, articles explaining the biology of neoplasia and congress reports including qualified comments. As a European journal “memo” aims at highlighting the local peculiarities of various regions and at being a forum for the presentation of ongoing clinical and basic research.
memo is the official Journal of the Central European Cooperative Oncology Group (CECOG) and
The Austrian Society of Haematology and medical Oncology (OeGHO).
memo – inoncology SPECIAL ISSUE
memo – inOncology SPECIAL ISSUE congress reports are a valuable medical education resource. Keeping lung cancer specialists up-to-date with the latest clinical trial data, and educating them on the finer points of clinical trial design and execution will ultimately result in higher standards of patient care. Thus, we are delighted that several societies distribute the magazine to their members. If you are interested in distributing the magazine to your members, free of charge, please email Elise Haidenthaller.
The memo – inOncology Medical education series: keeping oncologists at the forefront of lung cancer research. memo inOncology Special Issue Preceptorship reports summarise the latest in lung cancer research and treatments to come out of our sponsored Preceptorship meeting series. The Fundamentals of Designing Clinical Trials series arms oncologists with the information they need to plan and conduct an oncology trial.
For more information about memo – inOncology, please email Elise Haidenthaller.